Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01050205 · ClinicalTrials.gov registry record · NA

Diabetes Prevention Translation: the Healthy Lifestyle Project

A NA study of Diabetes and Cardiovascular Risk Factor, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
223
Enrollment target
1
Study location

NCT01050205 is a NA study of Diabetes and Cardiovascular Risk Factor that has completed, run by University of Pittsburgh. The registered enrollment target is 223 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01050205, a NA study of Diabetes and Cardiovascular Risk Factor, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
223 participants
Enrollment target
1
Study location

Study Summary

The Diabetes Prevention Program (DPP), a large research study conducted in the United States, found that lifestyle intervention was effective in lowering risk for development of type 2 diabetes. It is important to evaluate the DPP lifestyle interventions in "real world" settings. The purpose of this project is to test an adapted version of the DPP lifestyle intervention in several community settings, including a worksite, a health care facility (primary care practice and local community centers dedicated to older adults.

Interventions

  • BEHAVIORAL Current Intervention
  • BEHAVIORAL Delayed Intervention

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2010-09
Est. Completion 2015-03
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01050205

The ClinicalTrials.gov registry entry for NCT01050205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (93% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Current Intervention is the first listed.

NCT01050205 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01050205 about?

NCT01050205 is a clinical study titled "Diabetes Prevention Translation: the Healthy Lifestyle Project". The Diabetes Prevention Program (DPP), a large research study conducted in the United States, found that lifestyle intervention was effective in lowering risk for development of type 2 diabetes. It is important to evaluate the DPP lifestyle interventions in "real world" settings. The purpose of this...

What is the current status of trial NCT01050205?

This trial is currently completed. It is a NA study. The enrollment target is 223 participants. The study started on 2010-09. Estimated completion is 2015-03.

What conditions does trial NCT01050205 study?

This clinical trial studies the following conditions: Diabetes, Cardiovascular Risk Factor.

What interventions are being tested in trial NCT01050205?

The interventions under investigation include: Current Intervention (BEHAVIORAL), Delayed Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT01050205?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01050205 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.